Nanobiotix CEO’s Expansion Plans Target ‘Millions’ Of Patients

Nanobiotix’s Radio-Enhancer NBTXR3 Is Being Tested In Multiple Indications

 
• By Sten Stovall
  
Radiotherapy
Biotech wants to change how radiation is delivered to tumors • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas